Screening with serum galactomannan might be associated with better outcome than symptom-triggered galactomannan testing in allogeneic HSCT recipients with invasive aspergillosis.

Authors	Malgorzata Mikulska, Anna Maria Raiola, Alessio Signori, Elisa Furfaro, Valerio Del Bono, Andrea Bacigalupo, Claudio Viscoli
Journal	Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (Clin Infect Dis) Vol. 57 Issue 12 Pg. 1786-7 (Dec 2013) ISSN: 1537-6591 [Electronic] United States
PMID	24046295 (Publication Type: Letter, Comment)
Chemical References	Mannans
Topics	Female Hematopoietic Stem Cell Transplantation (mortality) Humans Invasive Pulmonary Aspergillosis (mortality) Male Mannans (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!